In This SectionTexas Health Research & Education Institute
Disease or Condition
The primary objective of this study is to collect data about patients' medical experiences and conditions following treatment of carotid artery stenosis (narrowing) using one of Abbott Vascular's carotid artery stent (metal coil) systems and embolic (blood clot) protection systems.
Patient or patient’s legally authorized representative provided informed consent.
Patient is considered at high risk for carotid endarterectomy (CEA). See Appendix 2 for the definition of a high risk patient.
Patient requires percutaneous carotid angioplasty and stenting for carotid artery disease.
Patient’s physician intends to use an RX Acculink with the RX Accunet or an Xact with the Emboshield in the carotid artery as per the FDA approved Indications for Use outlined below:
Patients with neurological symptoms and ≥ 50% stenosis of the common or internal carotid artery by ultrasound or angiogram.
Patients without neurological symptoms and ≥ 80% stenosis of the common or internal carotid artery by ultrasound or angiogram.